NEQSOL Holding Announces Second Phase of Women Leadership
AMSTERDAM, March 19, 2025 (GLOBE NEWSWIRE) -- NEQSOL Holding, an international group of companies serving over 25 million customers in...
Phase
CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial in India
CYTOMED THERAPEUTICS LIMITED SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based...
